Literature DB >> 15630445

Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity.

Lesley E Smythies1, Marty Sellers, Ronald H Clements, Meg Mosteller-Barnum, Gang Meng, William H Benjamin, Jan M Orenstein, Phillip D Smith.   

Abstract

Intestinal macrophages, which are thought to orchestrate mucosal inflammatory responses, have received little investigative attention compared with macrophages from other tissues. Here we show that human intestinal macrophages do not express innate response receptors, including the receptors for LPS (CD14), Fcalpha (CD89), Fcgamma (CD64, CD32, CD16), CR3 (CD11b/CD18), and CR4 (CD11c/CD18); the growth factor receptors IL-2 (CD25) and IL-3 (CD123); and the integrin LFA-1 (CD11a/CD18). Moreover, resident intestinal macrophages also do not produce proinflammatory cytokines, including IL-1, IL-6, IL-10, IL-12, RANTES, TGF-beta, and TNF-alpha, in response to an array of inflammatory stimuli but retain avid phagocytic and bacteriocidal activity. Thus, intestinal macrophages are markedly distinct in phenotype and function from blood monocytes, although intestinal macrophages are derived from blood monocytes. To explain this paradox, we show that intestinal stromal cell-derived products downregulate both monocyte receptor expression and, via TGF-beta, cytokine production but not phagocytic or bacteriocidal activity, eliciting the phenotype and functional profile of intestinal macrophages. These findings indicate a mechanism in which blood monocytes recruited to the intestinal mucosa retain avid scavenger and host defense functions but acquire profound "inflammatory anergy," thereby promoting the absence of inflammation characteristic of normal intestinal mucosa despite the close proximity of immunostimulatory bacteria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15630445      PMCID: PMC539188          DOI: 10.1172/JCI19229

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.

Authors:  J Savill; N Hogg; Y Ren; C Haslett
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

2.  Macrophage and monocyte IL-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing.

Authors:  D J Herzyk; J N Allen; C B Marsh; M D Wewers
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

3.  Regulation of intestinal epithelial cell growth by transforming growth factor type beta.

Authors:  J A Barnard; R D Beauchamp; R J Coffey; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

4.  Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.

Authors:  J Rugtveit; P Brandtzaeg; T S Halstensen; O Fausa; H Scott
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

5.  Regulation of transforming growth factor expression in rat intestinal epithelial cell lines.

Authors:  S Suemori; C Ciacci; D K Podolsky
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

6.  TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes.

Authors:  N McCartney-Francis; D Mizel; H Wong; L Wahl; S Wahl
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

7.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

8.  Transforming growth factor beta 1 selectively augments collagen synthesis by human intestinal smooth muscle cells.

Authors:  M F Graham; G R Bryson; R F Diegelmann
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

9.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

10.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

View more
  346 in total

1.  Distinct compartmentalization of NF-κB activity in crypt and crypt-denuded lamina propria precedes and accompanies hyperplasia and/or colitis following bacterial infection.

Authors:  Parthasarathy Chandrakesan; Ishfaq Ahmed; Anisha Chinthalapally; Pomila Singh; Shanjana Awasthi; Shrikant Anant; Shahid Umar
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice.

Authors:  Oscar Medina-Contreras; Duke Geem; Oskar Laur; Ifor R Williams; Sergio A Lira; Asma Nusrat; Charles A Parkos; Timothy L Denning
Journal:  J Clin Invest       Date:  2011-12       Impact factor: 14.808

Review 3.  Enterocytes: active cells in tolerance to food and microbial antigens in the gut.

Authors:  N Miron; V Cristea
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

4.  For gut's sake: NLRC4 inflammasomes distinguish friend from foe.

Authors:  Bernardo S Franklin; Eicke Latz
Journal:  Nat Immunol       Date:  2012-04-18       Impact factor: 25.606

5.  Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors:  B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

6.  Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria.

Authors:  Rawleigh Howe; Stephanie Dillon; Lisa Rogers; Martin McCarter; Caleb Kelly; Ricardo Gonzalez; Nancy Madinger; Cara C Wilson
Journal:  Clin Immunol       Date:  2009-01-25       Impact factor: 3.969

7.  JAK2 Disease-Risk Variants Are Gain of Function and JAK Signaling Threshold Determines Innate Receptor-Induced Proinflammatory Cytokine Secretion in Macrophages.

Authors:  Matija Hedl; Deborah D Proctor; Clara Abraham
Journal:  J Immunol       Date:  2016-09-23       Impact factor: 5.422

Review 8.  Macrophages: gatekeepers of tissue integrity.

Authors:  Yonit Lavin; Miriam Merad
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

Review 9.  Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages.

Authors:  B Kelsall
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

10.  Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis.

Authors:  P Goyette; C Lefebvre; A Ng; S R Brant; J H Cho; R H Duerr; M S Silverberg; K D Taylor; A Latiano; G Aumais; C Deslandres; G Jobin; V Annese; M J Daly; R J Xavier; J D Rioux
Journal:  Mucosal Immunol       Date:  2008-01-16       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.